Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesHope to commercialise 4 products acquired from Teva by FY18: DRL

SHOW NAMES

Trending Topics

Sensex Live Ceigall India Shares Pace Digitek IPO GMP Anand Rathi Share and Stock Brokers IPO

business

Hope to commercialise 4 products acquired from Teva by FY18: DRL

Saumen Chakraborty, CFO of the company told CNBC-TV18 that they hope to commercialise four out of the eight products by FY18. He said all the eight products are expected to have limited competition.

first published: Jun 13, 2016 02:12 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347